Clopidogrel resistance: myth or reality? - Wikidata - wikimedia - TriplyDB

Clopidogrel resistance: myth or reality?

Clopidogrel resistance: myth or reality?

http://www.wikidata.org/entity/Q28218055

about

The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Balancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome.Coronary stent thrombosis in patients with chronic renal insufficiency.Factors associated with clopidogrel nonresponsiveness.Antiplatelet therapy and vascular disease: an update.Global formulary review: how do we integrate pharmacogenomic information?Genetic determinants of platelet response to clopidogrel.Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis.Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications.

P2860

Q28220382-CCC894EB-AC08-4B27-88FD-7931BE5700D9 Q34771381-17516CD1-44F1-4070-8CD1-1A6D50CD3CC0 Q37311337-FBE62F24-A23A-4A59-8E11-12C48B64C49F Q37582058-86D01F95-1A86-4216-BC19-B5EF9B637FC6 Q37709405-9A205EE0-E062-44C8-B49E-DA2E1161DF8E Q37838100-42484E5B-BCE1-4E06-B11C-54D432F21D9F Q37864479-DB0A0008-4104-41AA-BD6D-CEDA7F06F3AD Q37894590-119F6118-549A-4B28-8DB8-EA637AA7BCB8 Q38396605-35D416F5-7E76-408F-92D0-81552BC4C7D4 Q43132755-DDF03398-4893-4251-AA6A-DA1997EF9920

P2860

Clopidogrel resistance: myth or reality?

http://www.wikidata.org/entity/Q28218055

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Clopidogrel resistance: myth or reality?

@ast

Clopidogrel resistance: myth or reality?

@en

Clopidogrel resistance: myth or reality?

@nl

type

label

Clopidogrel resistance: myth or reality?

@ast

Clopidogrel resistance: myth or reality?

@en

Clopidogrel resistance: myth or reality?

@nl

prefLabel

Clopidogrel resistance: myth or reality?

@ast

Clopidogrel resistance: myth or reality?

@en

Clopidogrel resistance: myth or reality?

@nl

P1433

Q28218055-74ADE595-8701-4B3E-A884-22244623A1E7

P1476

Q28218055-0A2A8251-79AB-4E7F-9F06-A5E786AE997F

P2093

Q28218055-6CD63237-E3BF-41E5-968D-9D5D969F1107

Q28218055-D620577A-4A2A-48E1-9F7D-796A70C7B41D

P2860

Q28218055-012BF675-81BC-4DF0-BB3C-EABFAA272E30

Q28218055-03B0B9B0-32FD-4045-823C-39A5994F4B00

Q28218055-09518BB5-9071-4F89-96FE-577E6E97576E

Q28218055-0D709FF2-B36A-4243-AA5C-0264D9426B45

Q28218055-1D0D8B7B-D9F5-493D-8C88-037FA40B16BF

Q28218055-1EEAEEA7-CB53-4DF2-A00A-469A7F97C8C4

Q28218055-33051FB1-110C-47C3-8F8A-E6B96B1F9EC6

Q28218055-55A18B2B-7B85-48E6-A168-846822688A77

Q28218055-5972049A-49F0-48A6-A5BB-4D91DEAC2B59

Q28218055-59D5F44F-C463-45A9-B2B7-8B37A0A8AA00

P304

Q28218055-EB83435D-5D4F-4AC9-BFDB-4D7BB5D38B06

P31

Q28218055-644bcea8-16ac-409c-99f6-dfe02f62ddc9

Q28218055-E5A239D5-74BD-469A-908E-529FB0797783

P356

Q28218055-B112FDA8-D3A5-48C8-829E-6E47093CE309

P407

Q28218055-090008B4-A00F-4227-B688-B037F1D7AB12

P433

Q28218055-E5C78EE6-226B-4244-ABEA-2EF075F1DBCE

P478

Q28218055-3CA135BE-2321-4458-BF9A-70EB445FDB31

P577

Q28218055-2BCDEE34-F630-4981-9DF1-7DF862587488

P5875

Q28218055-B3DD54DA-5BE0-4BF4-922F-61A3E95CE6AF

P698

Q28218055-D30BE3ED-4B8C-4EBD-9AD5-E856E4F493BE

P921

Q28218055-C64B70C9-93D7-4DB8-89B1-11958D72370C

P356

107424840601100104

P1433

Journal of Cardiovascular Pharmacology and Therapeutics

P1476

Clopidogrel resistance: myth or reality?

@en

P2093

Aron A Barsky

http://www.w3.org/2001/XMLSchema#string

Rohit R Arora

http://www.w3.org/2001/XMLSchema#string

P2860

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Role of antiplatelet drugs in the prevention of cardiovascular events

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

Aspirin resistance in cardiovascular disease: a review

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Clopidogrel resistance: a new chapter in a fast-moving story

Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study

P304

47-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107424840601100104

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7078793

http://www.w3.org/2001/XMLSchema#string

P698

16703219

http://www.w3.org/2001/XMLSchema#string

P921